Download PDFMarket Overview
The India Pharmaceutical Packaging Market was valued at USD ~ Million in 2024 and is anticipated to expand at a CAGR of ~ % during 2026–2035. The market is primarily driven by rising exports of generic medicines and vaccines, growth of biologics and specialty drug manufacturing, and increasing adoption of sustainable and tamper-evident packaging technologies. According to IMARC Group, the India pharmaceutical packaging market was valued at USD 1,907.15 million in 2024 and is projected to reach USD 3,447.8 million by 2033, with West and Central India currently dominating the market. India continues to play a pivotal role as a major global exporter of medicines and vaccines, sustaining consistent demand for compliant, high-performance packaging across oral drugs, injectables, biologics, and topical formulations serving both domestic and international pharmaceutical supply chains.
Market Segmentation
By Material
Among these, Plastics & Polymers hold the largest share of the India Pharmaceutical Packaging Market, accounting for approximately 41.32 percent of revenue in 2024 according to Mordor Intelligence, driven by widespread use across bottles, blister packs, and closures for oral solid dosage forms. Glass remains a critical material for injectable and biologic packaging formats, with demand particularly on the rise given its eco-friendly properties and suitability for various pharmaceutical products; Gerresheimer AG completed its acquisition of Bormioli Pharma in December 2024, bolstering borosilicate vial and cartridge supply for India-centric biologics exporters. At the same time, Composites & Bio-Based Resins represent the fastest-growing material segment, registering a 10.21 percent CAGR through 2030, supported by innovations such as the November 2024 introduction by UPM Biochemicals, Selenis, and Bormioli Pharma of the world’s first pharmaceutical bottles partially made from wood-based plastics using BioPET with UPM’s BioMEG, significantly reducing fossil resource dependency.
By Product Type
The Bottles segment holds the largest share, contributing approximately 21.43 percent of the India Pharmaceutical Packaging Market in 2024, reflecting the continued dominance of oral solid dosage forms across the country’s vast generics manufacturing base. Primary packaging as a whole held 60.23 percent of total market share in 2024 and is forecast to grow at a 9.21 percent CAGR through 2030, as bottles, blister packs, and strip packaging directly contact the medication and play a critical role in tamper-evidence and dosage integrity. Meanwhile, Pouches & Bags represent the fastest-growing product segment with a 9.54 percent CAGR through 2030, driven by rising demand for lightweight, flexible formats across powders, granules, and sachets. In parallel, Injectables and biologics packaging continue to expand rapidly, supported by India’s growing role as a vaccine and biologics exporter and by Berry Global’s January 2023 greenfield expansion in Bangalore, offering packaging solutions for inhalation, nasal, ophthalmic, dispensing, and self-injection applications.
Competitive Landscape
The India Pharmaceutical Packaging Market is moderately fragmented, with multinational packaging companies, established Indian converters, and specialized domestic manufacturers competing across plastic, glass, and flexible packaging formats. By end-user industry, pharmaceutical manufacturers retained the largest 49.98 percent share of the market in 2024, while contract packaging organizations (CPOs) expanded at a 10.11 percent CAGR through 2030, reflecting the growing trend of pharmaceutical companies outsourcing packaging operations. Recent developments illustrate the pace of investment in the sector: Uhlmann India celebrated the opening of a new office in October 2024, showcasing progress in blister packaging technology and localization initiatives, while ACG launched its ADAPT X feeder at CPHI & PMEC 2024 in Delhi in December 2024 to manage intricate and unconventional tablet forms. Domestic players such as Medipack Innovations Private Limited, Packtime Innovations Private Limited, North East Pharma Pack, and NS Industries leverage strategic collaborative initiatives to expand market share alongside global majors including Gerresheimer AG, Amcor plc, and West Pharmaceutical Services, Inc.
| Company | Establishment Year | Headquarters | Primary Product Portfolio | Pharmaceutical Packaging Portfolio
|
Manufacturing Presence | Major End-Use Industries | Key Strategic Focus | Certifications & Compliance |
| Gerresheimer AG | 1864 | ~ | ~ | ~ | ~ | ~ | ~ | ~ |
| Amcor plc | 1860 | ~ | ~ | ~ | ~ | ~ | ~ | ~ |
| West Pharmaceutical Services, Inc. | 1923 | ~ | ~ | ~ | ~ | ~ | ~ | ~ |
| Berry Global Group, Inc. | 1967 | ~ | ~ | ~ | ~ | ~<span data-ccp-props=”{“134233117″:false,”134233118″:false,”201341983″:0,”335551550″:1,”335551620″:1,”335559685”:0% |
- Executive Summary
- Research Methodology (Market Definitions and Assumptions, Abbreviations, Market Sizing Approach, Top-Down Analysis, Bottom-Up Analysis, Demand-Side Assessment, Supply-Side Assessment, Primary Industry Interviews, Secondary Research Validation, Data Triangulation, Forecasting Framework, Limitations and Future Conclusions)
- Definition and Scope
- Market Evolution and Industry Genesis
- Timeline of Major Industry Developments
- Pharmaceutical Packaging Industry Value Chain Analysis
- Supply Chain Analysis
- Growth Drivers (Rising Exports of Generic Medicines and Vaccines, Growth of Biologics and Specialty Drug Manufacturing, Expansion of Contract Packaging Organizations, Increasing Adoption of Sustainable and Bio-Based Packaging, Rising Healthcare Expenditure and Vaccination Initiatives, Government Support for Domestic Pharmaceutical Manufacturing)
- Market Challenges (Volatility in Plastic Resin and Glass Raw Material Prices, Regulatory Compliance Complexity Under CDSCO Requirements, Fragmented Domestic Packaging Industry Structure, High Cost of Track-and-Trace and Serialization Systems, Limited Domestic Borosilicate Glass Manufacturing Capacity, Competition from Low-Cost Regional Manufacturers)
- Market Opportunities (Investment in Sustainable and Bio-Based Packaging Materials, Growth in Prefilled Syringes and Vial Manufacturing, Expansion of Contract Packaging and Export-Oriented Capacity, Smart and Anti-Counterfeiting Packaging Technologies, Domestic Polymer Feedstock Availability Expansion, AI-Enabled Quality Analytics in Packaging Operations)
- Market Trends (Shift Toward Sustainable and Wood-Based Plastic Materials, Rising Adoption of Post-Consumer Recycled BOPET Films, Growth in Borosilicate Vial and Cartridge Capacity, Smart Packaging with Track-and-Trace Features, Expansion of Contract Packaging Organizations, Industry Consolidation Through Acquisitions)
- Government Regulations (Central Drugs Standard Control Organisation (CDSCO) Requirements, Drugs and Cosmetics Act 1940 and Rules 1945, Indian Pharmacopoeia (IP) Packaging Standards, Legal Metrology (Packaged Commodities) Rules, DGFT Track-and-Trace Barcoding Mandate for Pharmaceutical Exports, National Mission on Sustainable Packaging)
- Import and Export Analysis (Trade Volume, Major Import Sources, Export Destinations, HS Code Analysis, Trade Balance)
- Raw Material Availability Analysis (Pharmaceutical-Grade Resins, Borosilicate Glass, Aluminium Foil, Elastomeric Closures, Bio-Based and Wood-Derived Plastics)
- Technology Landscape (Serialization and Track-and-Trace Systems, Borosilicate Vial and Cartridge Manufacturing, Prefilled Syringe and Auto-Injector Assembly, Blister Packaging and Feeder Technologies, AI-Enabled Quality Analytics)
- Sustainability Assessment (Recyclability and Post-Consumer Recycled Content, Wood-Based Bio-Plastic Adoption, Carbon Footprint Reduction, National Mission on Sustainable Packaging Alignment, Circular Economy Integration)
- PESTLE Analysis
- SWOT Analysis
- Porter’s Five Forces Analysis
- Stakeholder Ecosystem
- Competition Ecosystem
- By Market Value (2020-2025)
- By Volume Consumption (2020-2025)
- By Average Selling Price (2020-2025)
- By Material (In Value %)
Plastics & Polymers
Glass
Composites & Bio-Based Resins
Aluminium Foil
Paper & Paperboard - By Product Type (In Value %)
Bottles
Blister Packs
Vials & Ampoules
Pouches & Bags
Strip Packaging
Prefilled Syringes - By Application (In Value %)
Oral Drugs
Injectables & Parenteral
Biologics & Vaccines
Topical Formulations
Nasal & Inhalation Products - By End Use (In Value %)
Pharmaceutical Manufacturers
Contract Packaging Organizations (CPOs)
Hospitals & Clinics
Retail & Export-Oriented Pharmacies - By Region (In Value %)
West & Central India
North India
South India
East India
- Market Share of Major Players (By Value, Volume, Material Type, Application Industry, Product Category)
- Cross Comparison Parameters (Material Portfolio Breadth, Sterile & Aseptic Packaging Capability, Drug Delivery Device Portfolio, Application Technical Support Capability, Manufacturing Capacity, Regulatory Compliance & Certifications, Pharmaceutical Customer Base, Innovation & New Product Launch Frequency)
- SWOT Analysis of Major Players
- Pricing Analysis by Product Category and SKU
- Production Capacity Analysis
- Manufacturing Footprint Analysis
- Distribution Network Analysis
- Innovation Benchmarking
- Detailed Profiles of Major Companies
Gerresheimer AG
Amcor plc
West Pharmaceutical Services, Inc.
Berry Global Group, Inc.
Medipack Innovations Private Limited
Catalent, Inc.
SCHOTT Pharmaceutical Packaging
AptarGroup, Inc.
Nipro Corporation
Becton, Dickinson and Company
SGD Pharma
CCL Industries Inc.
Packtime Innovations Private Limited
North East Pharma Pack
NS Industries
- Consumption Pattern Analysis (Industrial Usage, Batch Size, Product Category Penetration, Seasonal Demand, Reformulation Activity)
- Purchasing Criteria (Barrier Performance, Regulatory Compliance, Sterility Assurance, Cost Efficiency, Tamper-Evidence, Child-Resistance)
- Procurement and Supplier Selection Analysis
- Sustainable Packaging Adoption Assessment
- Premium vs Conventional Packaging Demand
- Product Attribute Preference Analysis (Barrier Properties, Extractables & Leachables Profile, Tamper-Evidence, Child-Resistance, Recyclability, Print and Traceability Quality)
- Patient Safety and Export Compliance Influence on Packaging Design
- Pain Point Analysis
- Decision-Making Process
- By Market Value (2026-2035)
- By Volume Consumption (2026-2035)
- By Average Selling Price (2026-2035)
Request a Sample
Ask for Customization
Get a Quote
Enquire Now